Should the Food and Drug Administration Limit Placebo-Controlled Trials?
Photo by Diana Polekhina on Unsplash ABSTRACT Randomized placebo-controlled trials are often used in clinical research, though there are ethical concerns regarding their use. The Food and Drug Administration (FDA) has rejected international stances on placebo-controlled trial use in favor of th...
Saved in:
Main Authors: | Max Goodman, Connor Pedersen |
---|---|
Format: | Article |
Language: | English |
Published: |
Columbia University Libraries
2022-07-01
|
Series: | Voices in Bioethics |
Subjects: | |
Online Access: | https://journals.library.columbia.edu/index.php/bioethics/article/view/9639 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Compliance with research participant protection guidelines by Nigerian medical journals
by: Adaora A. Onyiaorah, et al.
Published: (2025-01-01) -
Can oral caffeine decrease postoperative opioid consumption following posterior spinal fusion in adolescent idiopathic scoliosis? A randomized placebo-controlled trial
by: Anne Stuedemann, MSN, RN, CPNP, et al.
Published: (2025-03-01) -
La problemática de la racionalidad y la bioética
by: Roberto Estrada Olguín
Published: (2012-01-01) -
Response to Doctors for Life on assisted suicide
by: C A Joseph
Published: (2024-07-01) -
Comparison of Different Machine Learning Methodologies for Predicting the Non‐Specific Treatment Response in Placebo Controlled Major Depressive Disorder Clinical Trials
by: Roberto Gomeni, et al.
Published: (2025-01-01)